HEADER TOXIN/PROTEIN BINDING 09-NOV-06 2NUD TITLE THE STRUCTURE OF THE TYPE III EFFECTOR AVRB COMPLEXED WITH A HIGH- TITLE 2 AFFINITY RIN4 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AVIRULENCE B PROTEIN; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: RPM1-INTERACTING PROTEIN 4; COMPND 7 CHAIN: C, D; COMPND 8 FRAGMENT: RIN4 PEPTIDE, RESIDUES 142-176; COMPND 9 SYNONYM: RIN4; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS SYRINGAE PV. GLYCINEA; SOURCE 3 ORGANISM_TAXID: 318; SOURCE 4 STRAIN: PV GLYCINEA; SOURCE 5 GENE: AVRB; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEX-HTA; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: RIN4 PEPTIDE SYNTHESIZED NATURALLY FROM THE SOURCE 14 ARABIDOPSIS RIN4 SEQUENCE. N- AND C-TERMINI BLOCKED BY METHYLATION SOURCE 15 AND AMIDATION, RESPECTIVELY KEYWDS AVRB RIN4 HIGH-AFFINITY CRYSTAL STRUCTURE, TOXIN-PROTEIN BINDING KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.U.SINGER,D.DESVEAUX,A.J.WU,B.MCNULTY,J.SONDEK,J.L.DANGL REVDAT 3 30-AUG-23 2NUD 1 REMARK SEQADV REVDAT 2 24-FEB-09 2NUD 1 VERSN REVDAT 1 22-MAY-07 2NUD 0 JRNL AUTH D.DESVEAUX,A.U.SINGER,A.J.WU,B.C.MCNULTY,L.MUSSELWHITE, JRNL AUTH 2 Z.NIMCHUK,J.SONDEK,J.L.DANGL JRNL TITL TYPE III EFFECTOR ACTIVATION VIA NUCLEOTIDE BINDING, JRNL TITL 2 PHOSPHORYLATION, AND HOST TARGET INTERACTION. JRNL REF PLOS PATHOG. V. 3 E48 2007 JRNL REFN ISSN 1553-7366 JRNL PMID 17397263 JRNL DOI 10.1371/JOURNAL.PPAT.0030048 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.500 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1203820.950 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 26385 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.210 REMARK 3 FREE R VALUE : 0.260 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1273 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.007 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.44 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 87.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3867 REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE : 0.3120 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 185 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.023 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5012 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 44 REMARK 3 SOLVENT ATOMS : 321 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 36.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.31000 REMARK 3 B22 (A**2) : 0.24000 REMARK 3 B33 (A**2) : -2.54000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.42000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.20 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.36 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.31 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.200 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 21.90 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.750 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.960 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.050 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 3.100 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.290 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 42.79 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : TMN_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 5 : ETF_XPLOR_PAR.TXT REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : TMN_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 5 : ETF_XPLOR_TOP.TXT REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2NUD COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-NOV-06. REMARK 100 THE DEPOSITION ID IS D_1000040312. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-AUG-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU200 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : OSMIC CONFOCAL "BLUE" REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29016 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 99.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 88.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.10900 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.28 REMARK 200 COMPLETENESS FOR SHELL (%) : 72.7 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.43700 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1NH1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 38.02 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1:2-3 RATIO OF PROTEIN TO PEPTIDE WITH REMARK 280 AVRB AT ~12 MG/ML MIXED WITH AN EQUAL VOLUME OF WELL SOLUTION REMARK 280 (100 MM TRIS, PH 7.5, 20-30% PEG 550 MME), VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 29.08300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: CHAIN B AND D (AVRB AND PEPTIDE COMPLEX NO 2) ARE GENERATED REMARK 300 FROM CHAINS A AND C (COMPLEX NO 1) BY APPLYING THE TRANSFORMATION REMARK 300 TO COMPLEX 1 OF: [-1 0.0004 0.0008 + [-0.0584 -0.0004 -1 0.0023 - REMARK 300 10.7947 0.0008 0.0023 1 ] -59.8951] (IN THE FORM OF [X11 X12 X13 + REMARK 300 [Y1 X21 X22 X23 Y2 X31 X32 X33] Y3] ) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3470 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -2.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3650 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 1.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 THE AUTHORS STATE THAT FOR THE PEPTIDE (CHAINS C AND D), REMARK 400 THE N- AND C-TERMINI ARE BLOCKED (ACETYLATED AT THE REMARK 400 N-TERMINUS AND AMIDATED AT THE C-TERMINUS). REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -1 REMARK 465 ALA A 0 REMARK 465 MET A 1 REMARK 465 GLY A 2 REMARK 465 CYS A 3 REMARK 465 VAL A 4 REMARK 465 SER A 5 REMARK 465 SER A 6 REMARK 465 LYS A 7 REMARK 465 SER A 8 REMARK 465 THR A 9 REMARK 465 THR A 10 REMARK 465 VAL A 11 REMARK 465 LEU A 12 REMARK 465 SER A 13 REMARK 465 PRO A 14 REMARK 465 GLN A 15 REMARK 465 THR A 16 REMARK 465 SER A 17 REMARK 465 PHE A 18 REMARK 465 ASN A 19 REMARK 465 GLU A 20 REMARK 465 ALA A 21 REMARK 465 SER A 22 REMARK 465 ARG A 23 REMARK 465 THR A 24 REMARK 465 SER A 25 REMARK 465 SER A 54 REMARK 465 SER A 55 REMARK 465 GLN A 104 REMARK 465 ARG A 105 REMARK 465 GLY A 106 REMARK 465 GLY B -1 REMARK 465 ALA B 0 REMARK 465 MET B 1 REMARK 465 GLY B 2 REMARK 465 CYS B 3 REMARK 465 VAL B 4 REMARK 465 SER B 5 REMARK 465 SER B 6 REMARK 465 LYS B 7 REMARK 465 SER B 8 REMARK 465 THR B 9 REMARK 465 THR B 10 REMARK 465 VAL B 11 REMARK 465 LEU B 12 REMARK 465 SER B 13 REMARK 465 PRO B 14 REMARK 465 GLN B 15 REMARK 465 THR B 16 REMARK 465 SER B 17 REMARK 465 PHE B 18 REMARK 465 ASN B 19 REMARK 465 GLU B 20 REMARK 465 ALA B 21 REMARK 465 SER B 22 REMARK 465 ARG B 23 REMARK 465 THR B 24 REMARK 465 SER B 25 REMARK 465 SER B 54 REMARK 465 SER B 55 REMARK 465 GLN B 104 REMARK 465 ARG B 105 REMARK 465 GLY B 106 REMARK 465 PRO C 142 REMARK 465 GLU C 143 REMARK 465 LYS C 144 REMARK 465 VAL C 145 REMARK 465 THR C 146 REMARK 465 VAL C 147 REMARK 465 VAL C 148 REMARK 465 PRO C 149 REMARK 465 ARG C 173 REMARK 465 GLU C 174 REMARK 465 GLU C 175 REMARK 465 ARG C 176 REMARK 465 PRO D 142 REMARK 465 GLU D 143 REMARK 465 LYS D 144 REMARK 465 VAL D 145 REMARK 465 THR D 146 REMARK 465 VAL D 147 REMARK 465 VAL D 148 REMARK 465 PRO D 149 REMARK 465 ARG D 173 REMARK 465 GLU D 174 REMARK 465 GLU D 175 REMARK 465 ARG D 176 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU B 107 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 48 79.98 -114.08 REMARK 500 PRO A 130 31.41 -95.15 REMARK 500 ASN A 152 8.79 -68.46 REMARK 500 LEU A 175 -109.88 -109.83 REMARK 500 ASN B 152 8.52 -69.66 REMARK 500 LEU B 175 -110.12 -108.94 REMARK 500 PRO B 212 -33.84 -39.94 REMARK 500 MET B 262 72.82 49.10 REMARK 500 CYS B 320 -65.21 -100.05 REMARK 500 ASP C 155 59.01 -100.83 REMARK 500 SER C 161 151.51 -43.81 REMARK 500 ASP D 155 47.40 -101.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 1501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS B 1502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS B 1503 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TRS A 1504 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETF A 2001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ETF B 2002 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1NH1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TYPE III EFFECTOR AVRB FROM PSEUDOMONAS REMARK 900 SYRINGAE REMARK 900 RELATED ID: 2NUN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE TYPE III EFFECTOR AVRB COMPLEXED WITH ADP DBREF 2NUD A 1 321 UNP P13835 AVRB_PSESG 1 321 DBREF 2NUD B 1 321 UNP P13835 AVRB_PSESG 1 321 DBREF 2NUD C 142 176 UNP Q8GYN5 RIN4_ARATH 142 176 DBREF 2NUD D 142 176 UNP Q8GYN5 RIN4_ARATH 142 176 SEQADV 2NUD GLY A -1 UNP P13835 CLONING ARTIFACT SEQADV 2NUD ALA A 0 UNP P13835 CLONING ARTIFACT SEQADV 2NUD GLY B -1 UNP P13835 CLONING ARTIFACT SEQADV 2NUD ALA B 0 UNP P13835 CLONING ARTIFACT SEQRES 1 A 323 GLY ALA MET GLY CYS VAL SER SER LYS SER THR THR VAL SEQRES 2 A 323 LEU SER PRO GLN THR SER PHE ASN GLU ALA SER ARG THR SEQRES 3 A 323 SER PHE ARG ALA LEU PRO GLY PRO SER GLN ARG GLN LEU SEQRES 4 A 323 GLU VAL TYR ASP GLN CYS LEU ILE GLY ALA ALA ARG TRP SEQRES 5 A 323 PRO ASP ASP SER SER LYS SER ASN THR PRO GLU ASN ARG SEQRES 6 A 323 ALA TYR CYS GLN SER MET TYR ASN SER ILE ARG SER ALA SEQRES 7 A 323 GLY ASP GLU ILE SER ARG GLY GLY ILE THR SER PHE GLU SEQRES 8 A 323 GLU LEU TRP GLY ARG ALA THR GLU TRP ARG LEU SER LYS SEQRES 9 A 323 LEU GLN ARG GLY GLU PRO LEU TYR SER ALA PHE ALA SER SEQRES 10 A 323 GLU ARG THR SER ASP THR ASP ALA VAL THR PRO LEU VAL SEQRES 11 A 323 LYS PRO TYR LYS SER VAL LEU ALA ARG VAL VAL ASP HIS SEQRES 12 A 323 GLU ASP ALA HIS ASP GLU ILE MET GLN ASP ASN LEU PHE SEQRES 13 A 323 GLY ASP LEU ASN VAL LYS VAL TYR ARG GLN THR ALA TYR SEQRES 14 A 323 LEU HIS GLY ASN VAL ILE PRO LEU ASN THR PHE ARG VAL SEQRES 15 A 323 ALA THR ASP THR GLU TYR LEU ARG ASP ARG VAL ALA HIS SEQRES 16 A 323 LEU ARG THR GLU LEU GLY ALA LYS ALA LEU LYS GLN HIS SEQRES 17 A 323 LEU GLN ARG TYR ASN PRO ASP ARG ILE ASP HIS THR ASN SEQRES 18 A 323 ALA SER TYR LEU PRO ILE ILE LYS ASP HIS LEU ASN ASP SEQRES 19 A 323 LEU TYR ARG GLN ALA ILE SER SER ASP LEU SER GLN ALA SEQRES 20 A 323 GLU LEU ILE SER LEU ILE ALA ARG THR HIS TRP TRP ALA SEQRES 21 A 323 ALA SER ALA MET PRO ASP GLN ARG GLY SER ALA ALA LYS SEQRES 22 A 323 ALA GLU PHE ALA ALA ARG ALA ILE ALA SER ALA HIS GLY SEQRES 23 A 323 ILE GLU LEU PRO PRO PHE ARG ASN GLY ASN VAL SER ASP SEQRES 24 A 323 ILE GLU ALA MET LEU SER GLY GLU GLU GLU PHE VAL GLU SEQRES 25 A 323 LYS TYR ARG SER LEU LEU ASP SER ASP CYS PHE SEQRES 1 B 323 GLY ALA MET GLY CYS VAL SER SER LYS SER THR THR VAL SEQRES 2 B 323 LEU SER PRO GLN THR SER PHE ASN GLU ALA SER ARG THR SEQRES 3 B 323 SER PHE ARG ALA LEU PRO GLY PRO SER GLN ARG GLN LEU SEQRES 4 B 323 GLU VAL TYR ASP GLN CYS LEU ILE GLY ALA ALA ARG TRP SEQRES 5 B 323 PRO ASP ASP SER SER LYS SER ASN THR PRO GLU ASN ARG SEQRES 6 B 323 ALA TYR CYS GLN SER MET TYR ASN SER ILE ARG SER ALA SEQRES 7 B 323 GLY ASP GLU ILE SER ARG GLY GLY ILE THR SER PHE GLU SEQRES 8 B 323 GLU LEU TRP GLY ARG ALA THR GLU TRP ARG LEU SER LYS SEQRES 9 B 323 LEU GLN ARG GLY GLU PRO LEU TYR SER ALA PHE ALA SER SEQRES 10 B 323 GLU ARG THR SER ASP THR ASP ALA VAL THR PRO LEU VAL SEQRES 11 B 323 LYS PRO TYR LYS SER VAL LEU ALA ARG VAL VAL ASP HIS SEQRES 12 B 323 GLU ASP ALA HIS ASP GLU ILE MET GLN ASP ASN LEU PHE SEQRES 13 B 323 GLY ASP LEU ASN VAL LYS VAL TYR ARG GLN THR ALA TYR SEQRES 14 B 323 LEU HIS GLY ASN VAL ILE PRO LEU ASN THR PHE ARG VAL SEQRES 15 B 323 ALA THR ASP THR GLU TYR LEU ARG ASP ARG VAL ALA HIS SEQRES 16 B 323 LEU ARG THR GLU LEU GLY ALA LYS ALA LEU LYS GLN HIS SEQRES 17 B 323 LEU GLN ARG TYR ASN PRO ASP ARG ILE ASP HIS THR ASN SEQRES 18 B 323 ALA SER TYR LEU PRO ILE ILE LYS ASP HIS LEU ASN ASP SEQRES 19 B 323 LEU TYR ARG GLN ALA ILE SER SER ASP LEU SER GLN ALA SEQRES 20 B 323 GLU LEU ILE SER LEU ILE ALA ARG THR HIS TRP TRP ALA SEQRES 21 B 323 ALA SER ALA MET PRO ASP GLN ARG GLY SER ALA ALA LYS SEQRES 22 B 323 ALA GLU PHE ALA ALA ARG ALA ILE ALA SER ALA HIS GLY SEQRES 23 B 323 ILE GLU LEU PRO PRO PHE ARG ASN GLY ASN VAL SER ASP SEQRES 24 B 323 ILE GLU ALA MET LEU SER GLY GLU GLU GLU PHE VAL GLU SEQRES 25 B 323 LYS TYR ARG SER LEU LEU ASP SER ASP CYS PHE SEQRES 1 C 35 PRO GLU LYS VAL THR VAL VAL PRO LYS PHE GLY ASP TRP SEQRES 2 C 35 ASP GLU ASN ASN PRO SER SER ALA ASP GLY TYR THR HIS SEQRES 3 C 35 ILE PHE ASN LYS VAL ARG GLU GLU ARG SEQRES 1 D 35 PRO GLU LYS VAL THR VAL VAL PRO LYS PHE GLY ASP TRP SEQRES 2 D 35 ASP GLU ASN ASN PRO SER SER ALA ASP GLY TYR THR HIS SEQRES 3 D 35 ILE PHE ASN LYS VAL ARG GLU GLU ARG HET TRS A1501 8 HET TRS A1504 8 HET ETF A2001 6 HET TRS B1502 8 HET TRS B1503 8 HET ETF B2002 6 HETNAM TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL HETNAM ETF TRIFLUOROETHANOL HETSYN TRS TRIS BUFFER FORMUL 5 TRS 4(C4 H12 N O3 1+) FORMUL 7 ETF 2(C2 H3 F3 O) FORMUL 11 HOH *321(H2 O) HELIX 1 1 GLU A 38 CYS A 43 1 6 HELIX 2 2 THR A 59 ARG A 82 1 24 HELIX 3 3 SER A 87 LYS A 102 1 16 HELIX 4 4 LEU A 103 LEU A 103 5 1 HELIX 5 5 GLU A 107 PRO A 108 5 2 HELIX 6 6 LEU A 109 SER A 115 1 7 HELIX 7 7 TYR A 131 ASP A 140 1 10 HELIX 8 8 ASP A 183 GLY A 199 1 17 HELIX 9 9 GLY A 199 ASN A 211 1 13 HELIX 10 10 ASN A 219 SER A 221 5 3 HELIX 11 11 TYR A 222 ILE A 238 1 17 HELIX 12 12 SER A 243 MET A 262 1 20 HELIX 13 13 GLY A 267 HIS A 283 1 17 HELIX 14 14 VAL A 295 LEU A 302 1 8 HELIX 15 15 GLY A 304 LEU A 316 1 13 HELIX 16 16 GLU B 38 CYS B 43 1 6 HELIX 17 17 THR B 59 ARG B 82 1 24 HELIX 18 18 SER B 87 LYS B 102 1 16 HELIX 19 19 LEU B 109 SER B 115 1 7 HELIX 20 20 TYR B 131 ASP B 140 1 10 HELIX 21 21 ASP B 183 GLY B 199 1 17 HELIX 22 22 GLY B 199 ASN B 211 1 13 HELIX 23 23 ASN B 219 SER B 221 5 3 HELIX 24 24 TYR B 222 ILE B 238 1 17 HELIX 25 25 SER B 243 MET B 262 1 20 HELIX 26 26 GLY B 267 HIS B 283 1 17 HELIX 27 27 VAL B 295 LEU B 302 1 8 HELIX 28 28 GLY B 304 LEU B 316 1 13 HELIX 29 29 GLY C 152 GLU C 156 5 5 HELIX 30 30 GLY D 152 GLU D 156 5 5 SHEET 1 A 6 HIS A 145 ASP A 151 0 SHEET 2 A 6 GLY A 155 LEU A 168 -1 O LEU A 157 N MET A 149 SHEET 3 A 6 ASN A 171 ALA A 181 -1 O LEU A 175 N GLN A 164 SHEET 4 A 6 ARG A 214 ASP A 216 -1 O ASP A 216 N THR A 177 SHEET 5 A 6 THR A 121 PRO A 126 -1 N THR A 125 O ILE A 215 SHEET 6 A 6 HIS C 167 ASN C 170 -1 O HIS C 167 N VAL A 124 SHEET 1 B 6 HIS B 145 ASP B 151 0 SHEET 2 B 6 GLY B 155 LEU B 168 -1 O LEU B 157 N MET B 149 SHEET 3 B 6 ASN B 171 ALA B 181 -1 O VAL B 180 N LYS B 160 SHEET 4 B 6 ARG B 214 ASP B 216 -1 O ASP B 216 N THR B 177 SHEET 5 B 6 THR B 121 PRO B 126 -1 N THR B 125 O ILE B 215 SHEET 6 B 6 HIS D 167 ASN D 170 -1 O HIS D 167 N VAL B 124 CISPEP 1 LYS A 129 PRO A 130 0 0.27 CISPEP 2 LYS B 129 PRO B 130 0 0.34 SITE 1 AC1 7 ASP A 143 TYR A 162 ARG A 163 THR A 165 SITE 2 AC1 7 GLY A 304 HOH A1026 HOH A1268 SITE 1 AC2 6 TYR B 131 ALA B 269 VAL B 295 ASP B 297 SITE 2 AC2 6 HOH B1324 ETF B2002 SITE 1 AC3 3 THR B 118 ASP B 120 HOH B1310 SITE 1 AC4 7 ALA A 48 TRP A 50 TYR A 131 VAL A 295 SITE 2 AC4 7 ASP A 297 HOH A1318 ETF A2001 SITE 1 AC5 6 ARG A 266 GLY A 267 ALA A 269 HOH A1217 SITE 2 AC5 6 TRS A1504 HOH C1118 SITE 1 AC6 6 ARG B 266 GLY B 267 ALA B 269 HOH B1082 SITE 2 AC6 6 TRS B1502 HOH D1035 CRYST1 45.884 58.166 119.767 90.00 89.92 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021794 0.000000 -0.000029 0.00000 SCALE2 0.000000 0.017192 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008350 0.00000